BrainXell, Inc
Human iPSC-derived astrocyte platform for CNS drug discovery and screening
- Sector
- Biotech
- Headquarters
- MADISON, WI
- Latest Form D
- $13.2M, Sep 2021
- Total capital
- $18.1M
- Federal grants
- $4.4M
- 11 awards · 2016–2023
- Rank in peer group#34 of 42
- Private capital raised
- $13.2M
- 1 Form D · last Sep 2021
- 61 months since last filing
- Federal contracts
- $516K
- 9 awards · Health and Human S
- Rank in Biotech#230 of 4373
- Granted patents
- 0
- 9 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Brainxell, INC:1270448 [24-007322]$19K
- Federal grantHealth and Human S · Phase I · Accelerating Functional Maturation of Human iPSC-Derived Astrocytes$276K
- Private capital raisedForm D · SEC · 1st filing$13.2M
- Federal contractHealth and Human S · Brainxell, INC:1270448 [21-005362]$35K
- Federal contractHealth and Human S · Generation Of Stable Egfp-expressing Ipsc Line, Cat. No. BX-6021, Qty: 7; Differentiation To Spinal Motor Neurons From Ipscs, Cat. No. BX-6100, Qty: 4; And Shipping, Cat. No. SH-0500, Qty: 1.$131K
- Federal grantHealth and Human S · Phase I · Accelerating Functional Maturation of Human iPSC-Derived Microglia$255K
- Federal grantHealth and Human S · Phase II · Accelerating Functional Maturation of Human Neurons for High-Throughput Screening$609K
Show 14 earlier federal awards
- Federal contractHealth and Human S · Niaaa - Crispr Engineered Cells.$18K
- Federal contractHealth and Human S · This Purchase Order Is For Differentiated Neurons To Evaluate Infectivity Of Neurons With SARS-COV2.$12K
- Federal contractHealth and Human S · Exploratory Studies For Characterization Of Disease Phenotype In NGY1 Mutant Cortical Glutamatergic Neurons$20K
- Federal grantHealth and Human S · Phase II · Accelerating Functional Maturation of Human Neurons for High-Throughput Screening$700K
- Federal grantHealth and Human S · Phase I · Rapid Production of Regional and Disease Specific Human Astrocytes for CNS Drug Discovery$225K
- Federal contractHealth and Human S · Human Midbrain Dopaminergic Differentiation From Ipscs: 40 Vials At 2 Million Viable Cells/vial In 2 Batches. 10% Total Price Discount Included.$81K
- Federal contractHealth and Human S · Brainxell, INC:1270448 [18-006608] - Human Cortical Glutamatergic Neurons. Points Of Contact: Jennifer Kouznetsova And Wei Zheng.$100K
- Federal grantHealth and Human S · Phase II · Large-Scale Production of High Purity Human Cortical Glutamatergic Neurons$658K
- Federal contractHealth and Human S · Brainxell, INC:1270448 [18-001580]. Human Cortical Glutamatergic Neurons. Poc: Wei Zheng And Jennifer Kouznetsova.$100K
- Federal grantHealth and Human S · Phase II · Large-Scale Production of High Purity Human Cortical Glutamatergic Neurons$794K
- Federal grantHealth and Human S · Phase I · Accelerating Functional Maturation of Human Neurons for High-Throughput Screening$220K
- Federal grantHealth and Human S · Phase I · Patient Motor Neuron Assay System for ALS Drug Discovery$202K
- Federal grantHealth and Human S · Phase I · Accelerating Functional Maturation of Human Neurons for High-Throughput Screening$220K
- Federal grantHealth and Human S · Phase I · Large-Scale Production of High Purity Human Neurons for CNS Drug Discovery$222K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
66months
from BrainXell, Inc’s first federal award to its first private round.
- First federal award · Mar 2016
- Health and Human S · $222K
- First Form D · Sep 2021
- $13.2M · 1st Form D
- Awards before first raise
- 18 awards
An association in public records, not a cause or a prediction.
Standing among 42 peers
Line = medianBiotech · Platform
- Federal grantsBelow median
- Linked publications#1 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Chenfeng SongDirectorNamed in SEC Form D filings
- Ed BaetgeDirectorNamed in SEC Form D filings
- Shouming DuExecutive Officer, DirectorNamed in SEC Form D filings
- Su-Chun ZhangDirectorNamed in SEC Form D filings
- Xinjun LiangDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 9- PendingMethods Of Making, Expanding And Purifying Midbrain Dopaminergic Progenitor CellsUSPTOApplication 19315118
- PendingMethods And Compositions For Producing Stem Cell Derived Spinal Gaba Inhibitory Neurons For Use In Treatment Of Spinal Cord InjuryUSPTOApplication 18013642
- PendingMethods Of Making, Expanding And Purifying Midbrain Dopaminergic Progenitor CellsUSPTOApplication 17723026
Show all 9 patent records
- Methods Of Making, Expanding And Purifying Midbrain Dopaminergic Progenitor CellsFeb 26, 2026 · Application 19315118Pending
- Methods And Compositions For Producing Stem Cell Derived Spinal Gaba Inhibitory Neurons For Use In Treatment Of Spinal Cord InjuryOct 26, 2023 · Application 18013642Pending
- Methods Of Making, Expanding And Purifying Midbrain Dopaminergic Progenitor CellsOct 20, 2022 · Application 17723026Pending
- Reprogramming Cells With Synthetic Messenger RNAJul 1, 2021 · Application 16974280Pending
- Methods Of Making, Expanding And Purifying Midbrain Dopaminergic Progenitor CellsApplication PCTUS2022025224Pending
- Methods For Preserving Neural Progenitor Cell Survival In Vitro And In VivoApplication 63627583Pending
- Methods And Compositions For Producing Stem Cell Derived Spinal Gaba Inhibitory Neurons For Use In Treatment Of Spinal Cord InjuryApplication PCTUS2021040178Pending
- Methods Of Making, Expanding And Purifying Midbrain Dopaminergic Progenitor CellsApplication 63176006Pending
- Methods and Compositions for Producing Stem Cell Derived Spinal GABA Inhibitory Neurons for Use in Treatment of Spinal Cord InjuryApplication 63047697Pending
Recent research by its founders
- Cyclic hot solvent injection: An advantageous injection method compared with mixture solvent in the solvent based heavy oil mining process20260 cites
- Design of Measurement and Control System of Suspension Support Device Based on LabView and FPGA20250 cites
- Optimization of substrate formulation for Hericium erinaceus by replacing wood by straw and their effect on enzyme activities20248 cites
Related companies, and why
- Oleolive, Inc.Similar federal contract value in Biotech · $550K in contracts
- FERROLOGIX INCSimilar federal contract value in Biotech · $548K in contracts
- Hafion Inc.Similar federal contract value in Biotech · $536K in contracts
- VASCUMAB LLCSimilar federal contract value in Biotech · $502K in contracts
- Cocrystal Pharma, Inc.Similar federal contract value in Biotech · $498K in contracts
- Mirum PharmaceuticalsSimilar federal contract value in Biotech · $460K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .